Clinical Trial Update: Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection [NA]

View source ↗

Summary

This clinical trial update from Hannover Medical School discusses finite bulevirtide treatment for hepatitis D. It focuses on identifying biomarkers associated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D
• Liver Disease

Drugs mentioned

• Hepcludex (bulevirtide)

Snippet

Sponsor: Hannover Medical School | Conditions: Compensated Liver Disease (Disorder), Hepatitis D, Chronic | NA | Status: ACTIVE_NOT_RECRUITING